Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Napp Pharmaceuticals Ltd, Cambridge Science Park, Milton Road, Cambridge CB4 0GW
ADIZEM-XL capsules 120, 180, 200, 240 and 300 mg.
| Pharmaceutical Form |
|---|
|
Prolonged release capsule. Adizem-XL capsules 120 mg are approximately 16mm long with a pale pink body and a navy blue cap, marked DCR 120. Adizem-XL capsules 180 mg are approximately 18mm long with a dark pink body and a royal blue cap, marked DCR 180. Adizem-XL capsules 200 mg are approximately 19mm long with a light brown body and a light brown cap, marked DCR 200. Adizem-XL capsules 240 mg are approximately 19mm long with a dark red body and a blue cap, marked DCR 240. Adizem-XL capsules 300 mg are approximately 22mm long with a dark maroon body and a pale blue cap, marked DCR 300. |
Each capsule contains 120, 180, 200, 240 or 300 mg diltiazem hydrochloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diltiazem |
Diltiazem is a calcium antagonist. It restricts the slow channel entry of calcium into the cell and so reduces the liberation of calcium from stores in the sarcoplasmic reticulum. This results in a reduction of the amount of available intracellular calcium reducing myocardial oxygen consumption. |
| List of Excipients |
|---|
|
Capsule Contents: Microcrystalline cellulose Capsule shells: Iron oxide (E172) Printing ink: Shellac |
PVC/PVdC blister packs with aluminium foil (containing 28 capsules).
Napp Pharmaceuticals Ltd, Cambridge Science Park, Milton Road, Cambridge CB4 0GW
PL 16950/0010-0013, 0121
Adizem-XL Capsules 120, 180, 240, 300 mg:
Date of first authorisation: 11 August 1993
Date of latest renewal: 23 September 2003
Adizem-XL Capsules 200 mg:
Date of first authorisation: 10 September 2001
Date of latest renewal: 23 September 2003
| Drug | Countries | |
|---|---|---|
| ADIZEM | Ireland, Israel, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
